Articles related to BREAST SURGERY

The recent FDA approval of Lumicell’s breast cancer imaging system introduces a novel intraoperative tool that significantly enhances the precision of tumor resections, potentially reducing the need for subsequent corrective surgeries.

In an era where personalized treatment is paramount, the evolving landscape of axillary management in breast cancer stresses the shift towards minimizing surgical intervention while ensuring optimal patient outcomes.

This study reinforces the noninferiority of sentinel node biopsy in patients with clinically node-negative breast cancer, offering a potential paradigm shift in surgical decision-making and patient care.

This prospective cohort study presents compelling evidence that omitting radiotherapy in women over 55 with specific luminal A breast cancer characteristics may lead to a low incidence of local recurrence at 5 years.

With expert-led sessions encompassing a broad spectrum of breast disease management, from genetic risk assessment to cutting-edge oncological treatments, the course is a great opportunity to fortify your practice and enhance patient care.

The potential removal of the DIEP flap’s unique medical billing code by CMS could pose significant barriers to this beneficial breast reconstruction option, prompting calls for its preservation to ensure continued access and patient choice. Dive in to explore the implications of this pivotal issue for breast cancer patients and the health care system.